Anti-inflammatory drugs are medications that reduce inflammation, pain, and swelling by interrupting your body’s immune response at different points in the process. They fall into three broad categories: NSAIDs (like ibuprofen and naproxen), corticosteroids (like prednisone), and biologics (injectable drugs that target specific immune proteins). Which type is appropriate depends on the condition, its severity, and how long treatment is needed.
NSAIDs: The Most Common Type
Nonsteroidal anti-inflammatory drugs, or NSAIDs, are the anti-inflammatory medications most people encounter first. They work by blocking enzymes called COX-1 and COX-2, which your body uses to produce chemicals that trigger pain, swelling, and fever. By physically preventing the raw material (a fatty acid called arachidonic acid) from reaching these enzymes, NSAIDs shut down inflammation at its source.
The most familiar over-the-counter NSAIDs are ibuprofen (Advil, Motrin) and naproxen (Aleve). A standard dose of ibuprofen for mild to moderate pain is 400 mg every four to six hours as needed, while prescription doses for conditions like rheumatoid arthritis can range from 1,200 to 3,200 mg per day divided across several doses. Aspirin is also technically an NSAID, though it’s used more often for its blood-thinning properties than for inflammation. Prescription-strength NSAIDs include diclofenac, meloxicam, and celecoxib, which is designed to be more selective for the COX-2 enzyme.
That selectivity matters. COX-1 helps protect your stomach lining and supports kidney function, so blocking it indiscriminately is what causes many of the side effects people associate with these drugs. COX-2, on the other hand, is more directly involved in generating inflammation. Drugs that primarily target COX-2 were developed to reduce stomach problems, though they introduced cardiovascular concerns of their own.
Corticosteroids: Stronger and Broader
Corticosteroids like prednisone, prednisolone, and dexamethasone are synthetic versions of cortisol, a hormone your adrenal glands naturally produce. They suppress inflammation through a much wider set of mechanisms than NSAIDs. Once inside your cells, they bind to a receptor that travels into the nucleus and directly alters which genes get turned on or off. Specifically, they dial down the activity of two major inflammatory switches (known as NF-κB and AP-1) while boosting genes that calm the immune response.
Some of these effects happen remarkably fast. Within seconds to minutes of binding, corticosteroids can activate signaling pathways that block inflammatory proteins from entering the cell nucleus in the first place. This combination of rapid and slow-acting mechanisms is why a steroid dose pack can bring noticeable relief within hours for conditions like severe allergic reactions, asthma flares, or inflammatory bowel disease.
The tradeoff is that corticosteroids affect nearly every system in your body. Long-term use carries significant risks. Vertebral fractures occur in 21% to 30% of patients on prolonged steroid therapy, and cumulative exposure roughly doubles the risk of osteoporotic fractures overall. The risk of cataracts also increases by nearly twofold. Weight gain, elevated blood sugar, thinning skin, mood changes, and difficulty sleeping are common complaints even at moderate doses. For these reasons, doctors generally prescribe corticosteroids at the lowest effective dose for the shortest possible time, or use localized forms like inhalers, joint injections, or topical creams to limit whole-body exposure.
Biologics: Targeted Immune Therapy
Biologic anti-inflammatory drugs represent a newer, more targeted approach. Instead of broadly suppressing inflammation, they block specific proteins in the immune system that drive chronic inflammatory diseases. The most well-known category targets a protein called TNF-alpha, a chemical messenger that signals your cells to activate inflammatory processes. By preventing TNF-alpha from binding to its receptors, these drugs interrupt the chain reaction that sustains chronic inflammation in conditions like rheumatoid arthritis, Crohn’s disease, and psoriasis.
Five TNF inhibitors are currently FDA-approved: infliximab (Remicade), adalimumab (Humira), etanercept (Enbrel), certolizumab pegol (Cimzia), and golimumab (Simponi). Other biologics target different immune messengers, including interleukin-6 and interleukin-17. These drugs are given by injection or IV infusion, not taken as pills, and they’re reserved for autoimmune and autoinflammatory conditions that haven’t responded adequately to conventional treatments. Because they suppress specific parts of the immune system, they carry an increased risk of infections.
Cardiovascular Risks of NSAIDs
The FDA requires all non-aspirin NSAIDs to carry a warning about increased risk of heart attack and stroke. This isn’t a theoretical concern. A large meta-analysis found that COX-2 selective NSAIDs raised the risk of major coronary events by 76% and more than doubled the risk of heart failure hospitalization compared to placebo. Among traditional NSAIDs, diclofenac carried the highest cardiovascular risk, with a 63% increase in vascular events. Ibuprofen showed a 51% increase, though the result didn’t always reach statistical significance across studies. Naproxen consistently showed the most neutral cardiovascular profile, with no significant increase in vascular events compared to placebo.
This risk can appear early. Some observational studies found increased cardiovascular events within the first weeks of treatment, and the risk generally climbs with higher doses and longer use. The FDA’s guidance is straightforward: use the lowest effective dose for the shortest duration possible. People with existing heart disease face a higher absolute risk, even though the relative increase is similar to that seen in people without heart conditions.
Stomach, Kidney, and Bleeding Risks
Gastrointestinal damage is the classic NSAID side effect. By blocking COX-1, these drugs reduce the protective mucus layer in your stomach, which can lead to ulcers, bleeding, and perforation. This risk is higher in older adults, people with a history of stomach ulcers, and those taking corticosteroids at the same time.
Kidney damage is another serious concern. NSAIDs reduce blood flow to the kidneys, which can cause acute kidney injury or worsen existing chronic kidney disease. The National Kidney Foundation recommends that people with an eGFR below 60 (a measure of kidney function) avoid NSAIDs entirely. The same applies to people with liver disease, heart failure, or high blood pressure, and to those taking blood pressure medications like ACE inhibitors or diuretics.
If you’re taking a blood thinner, adding an NSAID substantially raises your bleeding risk. A meta-analysis found that combining NSAIDs with warfarin-type anticoagulants nearly tripled the risk of gastrointestinal bleeding (odds ratio of 2.66). Newer blood thinners paired with NSAIDs also showed a significant increase in overall bleeding risk, though the combination was somewhat safer than the warfarin pairing. The risk was most pronounced with nonselective NSAIDs, which tripled the odds of bleeding when taken alongside warfarin-type drugs.
Choosing the Right Type
For everyday aches, minor injuries, and menstrual cramps, over-the-counter NSAIDs are the standard starting point. They work well for short-term use in otherwise healthy people. Naproxen lasts longer per dose (about 12 hours versus 4 to 6 for ibuprofen), which can be more convenient, and it carries a more favorable cardiovascular profile.
Corticosteroids come into play when inflammation is more severe or widespread, such as in asthma attacks, lupus flares, or severe allergic reactions. They’re powerful but best used in short bursts or localized forms whenever possible. For chronic autoimmune conditions like rheumatoid arthritis or inflammatory bowel disease, the goal is often to use corticosteroids as a bridge while slower-acting medications take effect, then taper off.
Biologics are typically reserved for people with chronic autoimmune diseases who haven’t gotten adequate relief from other treatments. They require ongoing monitoring but can be transformative for conditions that previously had limited options. The choice between different biologics depends on the specific disease, how it has responded to prior treatment, and individual risk factors like infection history.